We recently compiled a list of the Jim Cramer Wants You to Watch Out For These 10 Stocks. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against the other stocks Jim Cramer wants you to watch out for.
Jim Cramer noted that Tuesday’s pullback was expected as the market had been rising for eight consecutive days, and a ninth would have taken it into rare territory, a streak not seen since 2004. The session was tough, with the Dow dropping 62 points and the S&P falling 2%, almost like a 33% loss. This raises the question of whether the market still has the momentum to keep climbing, especially since bad news finally caused stocks to drop, something that hadn’t happened much during the recent 8-day rally.
“We were due for today’s modest pullback—the S&P had been up for eight straight days, and nine straight would have put us in rarefied territory. We haven’t seen that kind of winning streak since 2004. Today’s session was rough, with the Dow off by 62 points and the S&P dipping 2%, like losing 33%. We have to wonder if the market still has the momentum to go higher because today we got bad news, and guess what—stocks actually went down. That didn’t happen much during the 8-day gain.”
Cramer observed an unusual trend during this winning streak. If a company reported better-than-expected earnings, the stock surged. Even if the results were only slightly better than feared, the stock still went up. And if a company posted disappointing earnings, the market shrugged it off, assuming it was the last bad quarter because the Fed might soon cut rates, so people kept buying anyway.
“You see, we had a very odd pattern during the winning streak. It was a bit of Pangloss and a nip of Camelot. When a company reported a better-than-expected quarter, it was great. When a company reported a quarter that was just better than feared, the stock still rose. And when a company reported a bad quarter, we decided that it was the last bad quarter because the Fed was about to cut rates, so it was no big deal—buy anyway. In other words, companies could do no wrong, but not today. Today, we had a bit of a reckoning, a dose of reality.”
Jim Cramer observed that the market had been enjoying a stretch where good performance boosted stocks, and even poor performance was cushioned by the belief that the Fed would step in to help. However, after seven consecutive days of gains, he pointed out that this optimistic pattern might be coming to an end. The market has now reached a level where stocks won’t automatically get the benefit of the doubt. Cramer explained that we’re back to a more typical environment where strong stocks rise and weaker ones fall. At these elevated levels, it’s no longer enough to dismiss the bearish outlook with a simple “heads I win, tails you lose” mindset.
“We’ve reached a point where the market is sufficiently elevated, and we’re back to business as usual—where the good stocks rise, and the bad ones fall. At these high levels, we can’t just dismiss the bears with “heads I win, tails you lose.” There’s a return to rationality, and rationality is the enemy of a market where everything rallies indiscriminately.”
Our Methodology
In this article, we reviewed a recent post of Jim Cramer and his latest insights on what to watch in the stock market for Tuesday. We highlighted ten stocks he mentioned and provided details on hedge fund sentiment for each. The stocks are ranked based on the number of hedge funds that own them, from lowest to highest.
At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
A surgeon in a modern operating room holding advanced medical devices with a sense of purpose and accuracy.
Medtronic plc (NYSE:MDT)
Number of Hedge Fund Investors: 52
Jim Cramer notes that Medtronic plc (NYSE:MDT) has recently seen several upgrades to its price targets following its earnings report on Tuesday. Baird raised its target from $82 to $90 per share but maintained a hold-equivalent rating, while Wells Fargo (NYSE:WFC) increased its target to $106 and kept an overweight rating.
“Medtronic picked up multiple price target bumps after its earnings report Tuesday. Baird goes to $90 a share from $82 but kept its hold-equivalent rating. Wells Fargo went up a dollar to $106 and maintained its overweight rating. Its neuromodulation business was a standout in the quarter.”
Medtronic plc (NYSE:MDT) is a major player in the medical device field, with a wide range of products across cardiovascular, diabetes, and neurological areas. Its large market share and global presence set the stage for ongoing growth. Medtronic plc (NYSE:MDT) is dedicated to innovation, shown by its strong lineup of new products and technologies, including advancements in robotic-assisted and minimally invasive surgeries. The introduction of the Hugo™ robotic-assisted surgery system highlights Medtronic’s strategy to stay ahead in the market and boost future revenue.
Recent financial reports show Medtronic plc (NYSE:MDT)’s steady revenue growth, with a 5% increase compared to last year, reflecting strong demand for its products. Medtronic plc (NYSE:MDT)’s focus on cost control and efficiency has improved its profit margins and financial health. As demand for advanced medical technologies rises and the global population ages, Medtronic plc (NYSE:MDT) is well-positioned to benefit from these trends. Recent acquisitions, like Mazor Robotics, have strengthened its capabilities in neurosurgery, which is expected to drive future growth and increase value for shareholders.
Overall MDT ranks 6th on our list of the stocks Jim Cramer wants you to watch out for. While we acknowledge the potential of MDT as an investment, our conviction lies in the belief that under the radar AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than MDT but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.
Disclosure: None. This article is originally published at Insider Monkey.